Patents by Inventor Tara JASKOWSKI

Tara JASKOWSKI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
    Publication number: 20230404918
    Abstract: The present disclosure provides methods of treating breast cancer including administering aqueous suspensions com-prising solubilized fulvestrant, non-solubilized fulvestrant particles having one or more of an LD Dv(1 0) between about 1.5 and about 2.1 microns, an LD Dv(50) between about 5.5 and about 9.0 microns, and an LD Dv(90) between about 15 and about 35 microns, with the aqueous suspensions further including a surfactant, a polyvinylpyrrolidone, and a sugar alcohol, and a water-soluble excipient. The water-soluble excipient can be an aryl-Ci-6alk-OH, a Ci-6alkyl-OH, a buffering salt, a polysorbate, a polyalkylene glycol, a Ci-i2alkylene glycol, a phosphatidylcholine, or a combination thereof.
    Type: Application
    Filed: February 14, 2023
    Publication date: December 21, 2023
    Inventors: Feng-Jing CHEN, Steven L. KRILL, Rama Abu SHMEIS, Adrian HEPNER, Charles WESCOTT, Tara JASKOWSKI, Michael JOYCE
  • Fulvestrant formulations and methods of their use
    Patent number: 11590077
    Abstract: The present disclosure provides methods of treating breast cancer including administering aqueous suspensions comprising solubilized fulvestrant, non-solubilized fulvestrant particles having one or more of an LD Dv(10) between about 1.5 and about 2.1 microns, an LD Dv(50) between about 5.5 and about 9.0 microns, and an LD Dv(90) between about 15 and about 35 microns, with the aqueous suspensions further including a surfactant, a polyvinylpyrrolidone, and a sugar alcohol, and a water-soluble excipient. The water-soluble excipient can be an aryl-Ci-6alk-OH, a Ci-6alkyl-OH, a buffering salt, a polysorbate, a polyalkylene glycol, a Ci-i2alkylene glycol, a phosphatidylcholine, or a combination thereof.
    Type: Grant
    Filed: November 8, 2018
    Date of Patent: February 28, 2023
    Assignee: Eagle Pharmaceuticals, Inc.
    Inventors: Feng-Jing Chen, Steven L. Krill, Rama Abu Shmeis, Adrian Hepner, Charles Wescott, Tara Jaskowski, Michael Joyce
  • FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
    Publication number: 20200360284
    Abstract: The present disclosure provides methods of treating breast cancer including administering aqueous suspensions comprising solubilized fulvestrant, non-solubilized fulvestrant particles having one or more of an LD Dv(10) between about 1.5 and about 2.1 microns, an LD Dv(50) between about 5.5 and about 9.0 microns, and an LD Dv(90) between about 15 and about 35 microns, with the aqueous suspensions further including a surfactant, a polyvinylpyrrolidone, and a sugar alcohol, and a water-soluble excipient. The water-soluble excipient can be an aryl-Ci-6alk-OH, a Ci-6alkyl-OH, a buffering salt, a polysorbate, a polyalkylene glycol, a Ci-i2alkylene glycol, a phosphatidylcholine, or a combination thereof.
    Type: Application
    Filed: November 8, 2018
    Publication date: November 19, 2020
    Inventors: Feng-Jing CHEN, Steven L. KRILL, Rama Abu SHMEIS, Adrian HEPNER, Charles WESCOTT, Tara JASKOWSKI, Michael JOYCE